A $5.6 million grant helps launch research to improve screening and treatment for a gynecologic disorder disproportionately impacting Black and Hispanic populations.

A large grant for Michigan Medicine will launch important research to improve the screening and treatment for a gynecologic disorder that disproportionately impacts Black and Hispanic populations

A melanoma survivor shares facts and tips about preventing all types of skin cancer.

Research published in PNAS examines how the bacteria Escherichia coli, or E. coli—responsible for most UTIs—is able to use host nutrients to reproduce at an extraordinarily rapid pace during infection despite the near sterile environment of fresh urine.

Researchers improved memory and reduced neuroinflammation in a mouse model of Alzheimer’s Disease, suggesting another avenue for potential treatment.

Malinda and David Morrison III welcomed their son in 2022 after years of trying to conceive

Four with Medical School ties are among 12 University of Michigan faculty and staff members recognized by the American Association for the Advancement of Science (AAAS) as 2023 fellows in recognition of their extraordinary achievements.

New map of the ovary provides a deeper understanding of how oocytes interact with the surrounding cells during the normal maturation process, and how the function of the follicles may break down in aging or fertility related diseases.

Survey shows many teens and young adults support making menstrual products more accessible to fight "period poverty."

A Michigan Medicine study finds that storing chemicals in a garage at home may associate with an increased risk of ALS.

At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests

How lipid mediators -- potent regulators of the immune response after an injury -- varied with the acute loss of a large volume of skeletal muscle, also known as volumetric muscle loss (VML) is the focus of new research from the University of Michigan.

Many women don’t get cervical cancer screening such as Pap tests, or don’t go for follow up diagnostic tests; a new study shows what could happen if all of them did.

Patients can now enroll in a clinical trial to test a groundbreaking nonsurgical treatment for cervical lesions that affect nearly 300,000 women in the United States every year.

Woman seeks answers for painful periods, leading to the discovery of endometriosis, large ovarian cysts, organ inflammation and appendix cancer